228 related articles for article (PubMed ID: 6135670)
1. [Genetic polymorphism of oxidative drug metabolism. Therapeutic and toxicologic implications].
Eichelbaum M
Internist (Berl); 1983 Mar; 24(3):117-27. PubMed ID: 6135670
[No Abstract] [Full Text] [Related]
2. Polymorphic drug oxidation in humans.
Eichelbaum M
Fed Proc; 1984 May; 43(8):2298-302. PubMed ID: 6714436
[TBL] [Abstract][Full Text] [Related]
3. [Heritable polymorphisms in oxidative drug metabolism].
Kallio J
Duodecim; 1990; 106(5):408-14. PubMed ID: 1670108
[No Abstract] [Full Text] [Related]
4. Genetic polymorphisms of drug metabolism.
Meyer UA; Zanger UM; Skoda RC; Grant D; Blum M
Prog Liver Dis; 1990; 9():307-23. PubMed ID: 2156298
[No Abstract] [Full Text] [Related]
5. Metabolic basis of adverse drug reactions.
Park BK
J R Coll Physicians Lond; 1986 Jul; 20(3):195-200. PubMed ID: 2874223
[No Abstract] [Full Text] [Related]
6. Polymorphic oxidation of debrisoquine and sparteine.
Eichelbaum M
Prog Clin Biol Res; 1986; 214():157-67. PubMed ID: 3523506
[No Abstract] [Full Text] [Related]
7. Pharmacogenetic polymorphism of drug metabolism.
Paxton JW
N Z Med J; 1984 Aug; 97(762):567-9. PubMed ID: 6591031
[No Abstract] [Full Text] [Related]
8. [Genetic polymorphism of the hepatic metabolism of drugs].
Larrey D; Pessayre D; Benhamou JP
Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
[No Abstract] [Full Text] [Related]
9. Genetically determined polymorphisms in drug oxidation.
Jacqz E; Hall SD; Branch RA
Hepatology; 1986; 6(5):1020-32. PubMed ID: 3758933
[No Abstract] [Full Text] [Related]
10. Ethnic differences in reactions to drugs and xenobiotics. Therapy.
Evans DA
Prog Clin Biol Res; 1986; 214():491-526. PubMed ID: 3523517
[No Abstract] [Full Text] [Related]
11. [Knowledge about metabolic capacity is important in drug therapy].
Alván G; Dahl ML
Lakartidningen; 1992 Feb; 89(6):382, 387-90. PubMed ID: 1738265
[TBL] [Abstract][Full Text] [Related]
12. The debrisoquine/sparteine oxidation polymorphism: evidence of genetic heterogeneity among Ghanaians.
Woolhouse NM
Prog Clin Biol Res; 1986; 214():189-206. PubMed ID: 3725761
[No Abstract] [Full Text] [Related]
13. Polymorphic drug metabolism.
Relling MV
Clin Pharm; 1989 Dec; 8(12):852-63. PubMed ID: 2689060
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of oxidation at carbon centers of drugs and their clinical significance.
Idle JR; Smith RL
Drug Metab Rev; 1979; 9(2):301-17. PubMed ID: 158499
[No Abstract] [Full Text] [Related]
15. Genetic polymorphism of drug metabolism in humans.
Gross AS; Kroemer HK; Eichelbaum M
Adv Exp Med Biol; 1991; 283():627-40. PubMed ID: 2069031
[No Abstract] [Full Text] [Related]
16. Pharmacogenetics and its clinical implications. Part II. Oxidation polymorphism.
Horai Y; Ishizaki T
Ration Drug Ther; 1988 Jun; 22(6):1-8. PubMed ID: 3051125
[No Abstract] [Full Text] [Related]
17. [The significance of cytochrome P450 gene superfamily for the clinical pharmacokinetics of drugs].
Brøsen K
Ugeskr Laeger; 1991 Feb; 153(6):417-22. PubMed ID: 2000644
[TBL] [Abstract][Full Text] [Related]
18. Defective oxidation of drugs: pharmacokinetic and therapeutic implications.
Eichelbaum M
Clin Pharmacokinet; 1982; 7(1):1-22. PubMed ID: 7042170
[No Abstract] [Full Text] [Related]
19. Stereo- and regioselectivity of hepatic oxidation in man--effect of the debrisoquine/sparteine phenotype on bufuralol hydroxylation.
Dayer P; Leemann T; Küpfer A; Kronbach T; Meyer UA
Eur J Clin Pharmacol; 1986; 31(3):313-8. PubMed ID: 2878813
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenetics of oxidation reactions of drugs].
Jacqz-Aigrain E
Arch Fr Pediatr; 1989 Jan; 46(1):59-65. PubMed ID: 2653266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
